HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Iron nanoparticles plus radiation: a new hope against Hard-to-Treat cancers?
Disease control Not yet recruitingThis phase 2 trial tests a new treatment for people with solid tumors like head and neck cancer or soft tissue sarcoma. The treatment combines an injection of carbon nanoparticle iron suspension (CNSI-Fe) directly into the tumor with standard radiation therapy. The goal is to see…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Sichuan Enray Pharmaceutical Sciences Company • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-phase trial tests whether a fluorescent dye attached to an immunotherapy drug can help surgeons see head and neck cancer cells during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The main goal is to check if the…
Matched conditions: HNSCC
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
Simple blood test could predict immunotherapy success in multiple cancers
Knowledge-focused Not yet recruitingThis study aims to develop a blood test that can predict whether a patient with certain cancers (like lung, skin, or breast cancer) will benefit from immunotherapy. Researchers will analyze a specific type of white blood cell (neutrophils) from blood samples taken before treatmen…
Matched conditions: HNSCC
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC